• Mashup Score: 4

    The FDA grants approval to sunvozertinib in NSCLC and linvoseltamab in myeloma and removes REMS requirements for approved CAR T-cell therapies.

    Tweet Tweets with this article
    • This is your sign 🛑 to catch up on last week's top 5 #oncology stories, including: ⭐️ 2 FDA approvals ⭐️ An FDA regulatory rundown ⭐️ Updates from the phase 3 FORTITUDE-101 trial Read it all here: https://t.co/9wtaU7SN2P https://t.co/i8FQ1Gmg9K